"Haloperidol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
| Descriptor ID |
D006220
|
| MeSH Number(s) |
D02.522.352.506
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Haloperidol".
Below are MeSH descriptors whose meaning is more specific than "Haloperidol".
This graph shows the total number of publications written about "Haloperidol" by people in this website by year, and whether "Haloperidol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1999 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 2 | 3 |
| 2010 | 0 | 2 | 2 |
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Haloperidol" by people in Profiles.
-
Personalized sedation goal for agitated delirium in patients with cancer: Balancing comfort and communication. Cancer. 2021 Dec 15; 127(24):4694-4701.
-
Association among rescue neuroleptic use, agitation, and perceived comfort: secondary analysis of a randomized clinical trial on agitated delirium. Support Care Cancer. 2021 Dec; 29(12):7887-7894.
-
Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial. Lancet Oncol. 2020 07; 21(7):989-998.
-
The minimal clinically important difference of the Richmond Agitation-Sedation Scale in patients with cancer with agitated delirium. Cancer. 2018 05 15; 124(10):2246-2252.
-
Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial. JAMA. 2017 09 19; 318(11):1047-1056.
-
Randomized Controlled Double-blind Trial Comparing Haloperidol Combined With Conventional Therapy to Conventional Therapy Alone in Patients With Symptomatic Gastroparesis. Acad Emerg Med. 2017 11; 24(11):1307-1314.
-
Neuroleptics for Delirium: More Research Is Needed. JAMA Intern Med. 2017 07 01; 177(7):1053-1054.
-
Neuroleptics for Delirium: More Research Is Needed. JAMA Intern Med. 2017 07 01; 177(7):1052-1053.
-
Neuroleptics in the management of delirium in patients with advanced cancer. Curr Opin Support Palliat Care. 2016 12; 10(4):316-323.
-
Managing Care of an Intrapartum Patient with Agitation and Psychosis: Ethical and Legal Implications. AMA J Ethics. 2016 Mar 01; 18(3):209-14.